Stock Detail
VANDA PHARMACEUTICALS INC
Sector: Biotechnology
Latest Quote @ Sun May 5 07:36:02 (15 min delayed)
| N/A |
N/A |
$6.58 |
+1.08 |
19.64% |
3.38M |
Last Day's Data
| $6.58 |
$7.23 |
$1.08 |
19.64% |
0.00 |
$5.50 |
| $6.22 |
$6.00 |
3.00 |
186.50M |
231,744.00 |
0.00 |
Pivot Table
| R2 |
R1 |
Pivot |
S1 |
S2 |
| 7.83 |
7.20 |
6.60 |
5.97 |
5.37 |
Stock Profile
Vanda Pharmaceuticals, Inc., a development stage biopharmaceutical company, focuses on the development and commercialization of clinical-stage drug candidates for various central nervous system disorders. It offers iloperidone, a compound for the treatment of schizophrenia and bipolar disorder; and VEC-162, a compound for the treatment of sleep and mood disorders. The company also provides VSF-173, a compound for the treatment of excessive sleepiness. Vanda Pharmaceuticals was founded in 2002 and is headquartered in Rockville, Maryland.
